CSIMarket
 
Pluri Inc   (NASDAQ: PLUR)
 

Pluri Inc's Suppliers Performance

PLUR's Supply Chain




 
PLUR Costs vs Sales of Suppliers Growth Pluri Inc's cost of sales deteriorated by -27.23 % year on year, sequentially cost of sales grew by 25.23 % in Q4.

More on PLUR Suppliers



Pluri Inc's cost of sales deteriorated by -27.23 % year on year, sequentially cost of sales grew by 25.23 % in Q4.

More on PLUR Suppliers




Pluri Inc's Comment on Supply Chain


The company collaborates with suppliers including bioreactor developers, scaffold technology providers, and producers of plant-derived ingredients, flavors, and food products. Ever After Foods is developing a proprietary technology platform for cultivated protein applications aimed at reducing costs and increasing production scale. Its plant-based FoodTech operations include Coffeesai, which focuses on cell-cultured coffee, and Kokomodo, which specializes in cell-cultured cacao and cocoa-derived ingredients. Coffeesai's market participants include California Cultured, Inc., Food Brewer AG, Another Food Pte. Ltd., and Atomo Foods, Inc. Kokomodo's market participants include Celleste Bio Ltd., California Cultured, Inc., and Food Brewer AG. Competitors in the plant-based FoodTech sector include DSM-Firmenich AG and Givaudan International SA. The company leverages proprietary technology, strategic partnerships, and regulatory developments to maintain competitiveness. Suppliers referenced in filings include Another Food Pte. Ltd., Atomo Foods, Inc., California Cultured, Inc., Celleste Bio Ltd., Coffeesai, DSM-Firmenich AG, Ever After Foods, Food Brewer AG, Givaudan International SA, Kokomodo, Pluri Biotech, and Tnuva.

Pluri Inc's Comment on Supply Chain


The company collaborates with suppliers including bioreactor developers, scaffold technology providers, and producers of plant-derived ingredients, flavors, and food products. Ever After Foods is developing a proprietary technology platform for cultivated protein applications aimed at reducing costs and increasing production scale. Its plant-based FoodTech operations include Coffeesai, which focuses on cell-cultured coffee, and Kokomodo, which specializes in cell-cultured cacao and cocoa-derived ingredients. Coffeesai's market participants include California Cultured, Inc., Food Brewer AG, Another Food Pte. Ltd., and Atomo Foods, Inc. Kokomodo's market participants include Celleste Bio Ltd., California Cultured, Inc., and Food Brewer AG. Competitors in the plant-based FoodTech sector include DSM-Firmenich AG and Givaudan International SA. The company leverages proprietary technology, strategic partnerships, and regulatory developments to maintain competitiveness. Suppliers referenced in filings include Another Food Pte. Ltd., Atomo Foods, Inc., California Cultured, Inc., Celleste Bio Ltd., Coffeesai, DSM-Firmenich AG, Ever After Foods, Food Brewer AG, Givaudan International SA, Kokomodo, Pluri Biotech, and Tnuva.







PLUR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Pluri Inc 10.72 1.02 -25.37 92
SUBTOTAL 0.00 0.00 0.00 -


Sources: Pluri Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Pluri Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.